Frequency of p12K and p12R alleles of HTLV type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers

AIDS Research and Human Retroviruses

Volumn 18, Issue 13, 2002, Pages 899-902

  Martins, M L ^a,b   Soares, B C ^a   Ribas, J G ^b   Thorun, G W ^b   Johnson, J ^c   Kroon, E G ^b   Carneiro Prioetti, A B ^a   Bonjardim, Cláudio A ^b  

^a FUNDAÇÃO HEMOMINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARGININE; CELL PROTEIN; INTERLEUKIN 2 RECEPTOR; LYSINE; PROTEASOME; VIRUS DNA; VIRUS PROTEIN;

ADULT; ALLELE; ARTICLE; CHROMOSOME 12P; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE FREQUENCY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; NEUROLOGIC DISEASE; OPEN READING FRAME; PAPILLOMA VIRUS; PHENOTYPE; POPULATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUBLICATION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS CARRIER; VIRUS GENOME; VIRUS INFECTION;

ADULT; ALLELES; CARRIER STATE; FEMALE; GENE FREQUENCY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PARAPARESIS, TROPICAL SPASTIC; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 0036385707     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202760265560     Document Type: Article

References (9)

1. Uchiyama T: Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37.
2. Berneman ZN, Gartenhaus RB, Reitz MS Jr, Blattner WA, Manns A, Hanchard B, Ikehara O, Gallo RC, and Klotman ME: Expression of alternatively spliced human T-lymphotropic virus type 1 (HTLV-I) pX mRNA in infected cell lines and primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci USA 1992;89:3005-3009.
3. I protein greatly influences its stability. J Virol 1999;73:6460-6467.
4. Collins ND, Newboun GC, Albrecht B, Beard JL, Ratner L, and Lairmore MD: Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 1998;91:4701-4707.
5. + ATPase. J Virol 1993;67:7701-7704.
6. c chains and affects their expression on the cell surface. J Virol 1996;70:3599-3605.
7. I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 2001;98:823-829.
8. I protein. J Virol 2001;75:6086-6094.
9. Franchini G: Molecular mechanisms of the human T-cell leukemia/lymphotropic virus type I infection. Blood 1995;86:3619-3639.